Literature DB >> 6605395

Antibody-dependent cell-mediated cytotoxicity against influenza virus-infected cells.

G Hashimoto, P F Wright, D T Karzon.   

Abstract

The three major immunocompetent cells in human peripheral blood (lymphocytes, neutrophils, and monocytes) were shown to be effector cells for antibody-dependent cell-mediated cytotoxicity (ADCC) against influenza virus-infected baby hamster kidney cells in vitro. Lymphocyte cytotoxicity was mediated by FcIgG receptor-bearing null cells and T gamma cells. These effector populations were best defined by HNK-1, a monoclonal antibody to human natural killer and ADCC-mediator cells. Antibody responsible for ADCC against influenza virus-infected cells was detectable in sera of young children after natural infection and after vaccination with inactivated and live attenuated viruses. ADCC antibody appeared before hemagglutination-inhibiting antibody and persisted for at least one year after vaccination with live attenuated vaccine. ADCC antibody was subtype-specific but quite broadly reactive within a subtype. Both hemagglutinin and neuraminidase were antigenic determinants for ADCC antibody. An anamnestic response to the original strain was observed after challenge with influenza virus of a heterologous subtype.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6605395     DOI: 10.1093/infdis/148.5.785

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  66 in total

1.  Determining the phagocytic activity of clinical antibody samples.

Authors:  Elizabeth G McAndrew; Anne-Sophie Dugast; Anna F Licht; Justin R Eusebio; Galit Alter; Margaret E Ackerman
Journal:  J Vis Exp       Date:  2011-11-30       Impact factor: 1.355

2.  rVSV(M Delta 51)-M3 is an effective and safe oncolytic virus for cancer therapy.

Authors:  Lan Wu; Tian-gui Huang; Marcia Meseck; Jennifer Altomonte; Oliver Ebert; Katsunori Shinozaki; Adolfo García-Sastre; John Fallon; John Mandeli; Savio L C Woo
Journal:  Hum Gene Ther       Date:  2008-06       Impact factor: 5.695

3.  Generation and Protective Ability of Influenza Virus-Specific Antibody-Dependent Cellular Cytotoxicity in Humans Elicited by Vaccination, Natural Infection, and Experimental Challenge.

Authors:  Sinthujan Jegaskanda; Catherine Luke; Heather D Hickman; Mark Y Sangster; Wendy F Wieland-Alter; Jacqueline M McBride; Jon W Yewdell; Peter F Wright; John Treanor; Carrie M Rosenberger; Kanta Subbarao
Journal:  J Infect Dis       Date:  2016-06-28       Impact factor: 5.226

4.  Antibody Responses with Fc-Mediated Functions after Vaccination of HIV-Infected Subjects with Trivalent Influenza Vaccine.

Authors:  Anne B Kristensen; William N Lay; Fernanda Ana-Sosa-Batiz; Hillary A Vanderven; Vijaya Madhavi; Karen L Laurie; Louise Carolan; Bruce D Wines; Mark Hogarth; Adam K Wheatley; Stephen J Kent
Journal:  J Virol       Date:  2016-05-27       Impact factor: 5.103

5.  High-throughput quantitative analysis of HIV-1 and SIV-specific ADCC-mediating antibody responses.

Authors:  Justin Pollara; Lydia Hart; Faraha Brewer; Joy Pickeral; Beverly Z Packard; James A Hoxie; Akira Komoriya; Christina Ochsenbauer; John C Kappes; Mario Roederer; Ying Huang; Kent J Weinhold; Georgia D Tomaras; Barton F Haynes; David C Montefiori; Guido Ferrari
Journal:  Cytometry A       Date:  2011-07-06       Impact factor: 4.355

6.  Relationship of preexisting influenza hemagglutination inhibition, complement-dependent lytic, and antibody-dependent cellular cytotoxicity antibodies to the development of clinical illness in a prospective study of A(H1N1)pdm09 Influenza in children.

Authors:  Mary Dawn T Co; Masanori Terajima; Stephen J Thomas; Richard G Jarman; Kamonthip Rungrojcharoenkit; Stefan Fernandez; In-Kyu Yoon; Darunee Buddhari; John Cruz; Francis A Ennis
Journal:  Viral Immunol       Date:  2014-08-20       Impact factor: 2.257

7.  Identification of dominant antibody-dependent cell-mediated cytotoxicity epitopes on the hemagglutinin antigen of pandemic H1N1 influenza virus.

Authors:  Vikram Srivastava; Zheng Yang; Ivan Fan Ngai Hung; Jianqing Xu; Bojian Zheng; Mei-Yun Zhang
Journal:  J Virol       Date:  2013-03-13       Impact factor: 5.103

8.  Role for macrophage inflammatory protein 2 (MIP-2), MIP-1alpha, and interleukin-1alpha in the delayed-type hypersensitivity response to viral antigen.

Authors:  Terrence M Tumpey; Robin Fenton; Sara Molesworth-Kenyon; John E Oakes; Robert N Lausch
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

9.  Protection of mice against an influenza virus infection by oral vaccination with viral nucleoprotein incorporated into immunostimulating complexes.

Authors:  K Scheepers; H Becht
Journal:  Med Microbiol Immunol       Date:  1994-11       Impact factor: 3.402

10.  Neuraminidase-inhibiting antibody is a correlate of cross-protection against lethal H5N1 influenza virus in ferrets immunized with seasonal influenza vaccine.

Authors:  Steven Rockman; Lorena E Brown; Ian G Barr; Brad Gilbertson; Sue Lowther; Anatoly Kachurin; Olga Kachurina; Jessica Klippel; Jesse Bodle; Martin Pearse; Deborah Middleton
Journal:  J Virol       Date:  2013-01-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.